Biotech · Private company
Lakewood-Amedex Inc
Track this companyFree. Adds Lakewood-Amedex Inc to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- 10% Bisphosphocin Topical GelPhase 2 · Chronic Diabetic Foot UlcersClinicalTrials.gov · fetched Nov 12, 2026
- 5% Bisphosphocin Topical GelPhase 2 · Chronic Diabetic Foot UlcersClinicalTrials.gov · fetched Nov 12, 2026
- Antimicrobial agentPhase 2 · Diabetic Foot Ulcers (DFUs)ClinicalTrials.gov · fetched Nov 12, 2026
- Bisphosphocin Nu-3Phase 2 · Diabetic Foot InfectionsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Phase 2a Dose Finding Study of Nu-3 Gel in Subjects With Mild iDFUPHASE2 · RECRUITING · started Aug 14, 2026ClinicalTrials.gov NCT07565506 · fetched Nov 12, 2026
- Nu-3 Topical Gel for Treatment of Diabetic Foot UlcerPHASE2 · TERMINATED · started Mar 11, 2022ClinicalTrials.gov NCT05276401 · fetched Nov 12, 2026
- Topically Applied Bisphosphocin Nu-3 on Infected Diabetic Ulcers of Subjects With Type I or II Diabetes MellitusPHASE1_PHASE2 · COMPLETED · started Apr 1, 2016ClinicalTrials.gov NCT02737722 · fetched Nov 12, 2026